Patents by Inventor Kent A. Nielsen

Kent A. Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220170003
    Abstract: The present invention relates to means and methods for improving protease expression by co-expression with a foldase.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 2, 2022
    Applicant: Novozymes A/S
    Inventors: Ane Quesada Ganuza, Michael Dolberg Rasmussen, Allan Kent Nielsen
  • Publication number: 20220112478
    Abstract: The present invention relates to means and methods for optimizing expression of a heterologous polypeptide of interest in Gram-positive host cells by co-expression with a foldase that is cognate to the heterologous polypeptide of interest.
    Type: Application
    Filed: January 22, 2020
    Publication date: April 14, 2022
    Applicant: Novozymes A/S
    Inventors: Ane Quesada Ganuza, Michael Dolberg Rasmussen, Allan Kent Nielsen
  • Patent number: 8535911
    Abstract: A progeny cell derived from a parent cell, wherein the progeny cell comprises at least one gene encoding MrgA protein or a functional homologue thereof and/or a DNA segment operably linked with the encoding gene, wherein said gene and/or DNA segment is manipulated with respect to the parent cell; the progeny cell comprises two or more copies of a gene encoding MrgA protein or a functional homologue thereof; or the progeny cell is mutated with respect to the parent cell; whereby the progeny cell produces greater amounts of MrgA protein or a functional homologue thereof than the parent cell.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: September 17, 2013
    Assignee: Novosymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen
  • Patent number: 8378093
    Abstract: The present invention relates to a porphyrinogen based sensor having selective binding affinity for an explosive chemical. Upon binding of the target molecule, the porphyrinogen derivative undergoes a detectable adsorption and emission of electromagnetic radiation.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: February 19, 2013
    Assignee: Syddansk Universitet
    Inventors: Jan Oskar Jeppesen, Kent A. Nielsen
  • Patent number: 8268583
    Abstract: A progeny cell derived from a parent cell, wherein the progeny cell comprises at least one gene encoding MrgA protein or a functional homologue thereof and/or a DNA segment operably linked with the encoding gene, wherein said gene and/or DNA segment is manipulated with respect to the parent cell; the progeny cell comprises two or more copies of a gene encoding MrgA protein or a functional homologue thereof; or the progeny cell is mutated with respect to the parent cell; whereby the progeny cell produces greater amounts of MrgA protein or a functional homologue thereof than the parent cell.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: September 18, 2012
    Assignee: Novozymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen
  • Publication number: 20110306139
    Abstract: A mutated bacterial cell producing at least one heterologous polypeptide of interest, wherein said cell has a reduced expression-level of a polypeptide comprising an amino acid sequence at least 70% identical to the sequence shown in SEQ ID NO: 2, when compared with an otherwise isogenic but non-mutated cell; methods for producing said mutated cell; and methods for producing a polypeptide of interest using said mutated cell. SEQ ID NO: 2 represents a putative metalloprotease.
    Type: Application
    Filed: February 25, 2010
    Publication date: December 15, 2011
    Applicant: Novozymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen, Niels Banke
  • Patent number: 7951556
    Abstract: A mutated prokaryotic cell, which secretes higher amounts of at least one heterologous polypeptide of interest and which has a reduced expression-level of YusZ or YusX, or homologues thereof, when compared with an otherwise isogenic but non-mutated cell, and methods for constructing and using such a cell in the production of polypeptides.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: May 31, 2011
    Assignee: Novozymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen
  • Publication number: 20110003396
    Abstract: The present invention relates to a porphyrinogen based sensor having selective binding affinity for an explosive chemical. Upon binding of the target molecule, the porphyrinogen derivative undergoes a detectable adsorption and emission of electromagnetic radiation.
    Type: Application
    Filed: May 15, 2007
    Publication date: January 6, 2011
    Applicant: SYDDANSK UNIVERSITET
    Inventors: Jan O. Jeppesen, Kent A. Nielsen
  • Publication number: 20100173286
    Abstract: A mutated bacterial cell producing at least one heterologous polypeptide of interest, wherein said cell has a reduced expression-level of YugJ (SEQ ID NO: 2) or a homologue thereof when compared with an otherwise isogenic but non-mutated cell; methods for producing said cell, and methods for producing a polypeptide of interest using said cell.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 8, 2010
    Applicant: Novozymes A/S
    Inventors: Jon Martin Persson, Allan Kent Nielsen, Niels Banke
  • Publication number: 20090239757
    Abstract: The present invention relates to a method of identifying control sequences responding to antimicrobial peptides (AMPs), to host cells expressing an AMP and comprising a control sequence of the invention operable linked to a reporter, and to a method of screening for novel AMPs or AMP-variants having improved antimicrobial activity. Particularly the present invention relates to DNA control sequences, wherein the transcriptional profiles of said control sequences are regulated by the presence of an antimicrobial polypeptide expressed inside the host cell.
    Type: Application
    Filed: December 20, 2005
    Publication date: September 24, 2009
    Applicant: Novozymes A/S
    Inventors: Jesper Duus Nielsen, Allan Kent Nielsen, Bjarke Christensen, Poul Erik Pedersen, Hans-Henrik Kristensen Hoegenhaug
  • Publication number: 20090136995
    Abstract: A mutated prokaryotic cell, which secretes higher amounts of at least one heterologous polypeptide of interest and which has a reduced expression-level of YusZ or YusX, or homologues thereof, when compared with an otherwise isogenic but non-mutated cell, and methods for constructing and using such a cell in the production of polypeptides.
    Type: Application
    Filed: April 7, 2005
    Publication date: May 28, 2009
    Applicant: Novozymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen
  • Publication number: 20050143599
    Abstract: A process for preparing monoesters comprises the step of reacting at least one diol with at least one carboxylic acid in a biphasic solvent system, the carboxylic acid being sufficiently water soluble to allow esterification to occur, and the biphasic solvent system comprising water and at least one aprotic solvent in which the resulting monoester has greater solubility than in water.
    Type: Application
    Filed: December 30, 2003
    Publication date: June 30, 2005
    Inventors: Markus Wicki, Kent Nielsen